FDA aims to better understand immunotherapy in the ‘real world’ – OutSourcing-Pharma.com
OutSourcing-Pharma.com |
FDA aims to better understand immunotherapy in the ‘real world’
OutSourcing-Pharma.com However, following FDA-approval of immunotherapies to treat various cancer, Kush explained the agency “wishes to better understand the safety effects of such drugs in the ‘real world,’ in addition to safety data from clinical trials.” To do so, the US … |
|
‘CRISPR-Gold’ repairs muscular dystrophy gene in mouse model
BioNews Scientists have repaired the faulty gene in a mouse model of muscular dystrophy by using gold nanoparticles to deliver the genome editing tool CRISPR/Cas9. The new system, termed CRISPR-Gold, overcomes some issues associated with viral vectors, … |
|
‘CRISPR-Gold’ repairs muscular dystrophy gene in mouse model
BioNews Scientists have repaired the faulty gene in a mouse model of muscular dystrophy by using gold nanoparticles to deliver the genome editing tool CRISPR/Cas9. The new system, termed CRISPR-Gold, overcomes some issues associated with viral vectors, … |